Abbott Korea, Esai Korea co-promote Humira Pen

Published: 2007-12-20 06:58:00
Updated: 2007-12-20 06:58:00
Abbott Korea and Esai Korea said they are co-marketing Humira Pen, a new device for administering Humira (adalimumab), a treatment approved for moderate to severe rheumatoid arthritis and psoriatic arthritis.

With its one-touch activation and easy-to-grasp size and shape, the Humira Pen offers...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.